Post #733 by commonone on the US Policy board

When visiting Shrewd'm with a laptop, it can be pleasant to hold Command (or Ctrl with Windows) and '+' a few times. The site scales to allow any font size, and the larger font can be pleasant to read even for Shrewds with perfect sight! For luxury Shrewdness, you can combine that with setting the browser to full screen. You'll then find yourself Shrewding a lot.

- Manlobbi

Halls of Shrewd'm / US Policy

Unthreaded | Threaded | Whole Thread (2)

Prev | Next

Post New | Post Reply | Report Post | Recommend It!

No. of Recommendations: 8

Sanofi joins Eli Lilly and Novo Nordisk -- the three pharmaceutical companies that make up about 90% of the insulin market in the U.S. -- and announces price cuts or out-of-pocket caps.

Sanofi will cap the out-of-pocket cost of its most popular insulin, Lantus, at $35 per month for people with private insurance, the French drugmaker said Thursday. The change will take effect Jan. 1, 2024.

Sanofi is the last of three major insulin makers in the United States to cut or cap the price of the drug.

Had Trump been able to pull this off, he would have demanded a ticker-tape parade in every major city in America and awarded himself the Congressional Medal of Honor.

https://www.nbcnews.com/health/health-news/sanofi-...

Post New | Post Reply | Report Post | Recommend It!

Print the post

Unthreaded | Threaded | Whole Thread (2)

Prev | Next

Announcements

US Policy FAQ

Contact Shrewd'm
Contact the developer of these message boards.

A community forum supporting civilized, and highly helpful, self-educating investors that come together for Shrewdness and merry spirits. These message boards closely follow the look and feel of the old message boards at boards.fool.com prior to the boards redirected to discussion.fool.com. Shrewd'm is not affiliated with the comprehensive and excellent investment website, The Motley Fool (TMF), in any way. The Shrewd commmunity here has owed, and continues to owe, gratitude to The Motley Fool for nurturing a culture of jovial irreverence towards Wall St, and that tradition will continue here.